KZA 0.00% 8.0¢ kazia therapeutics limited

Interim Results of Phase 2 GBM Trial Released, page-5

  1. 352 Posts.
    lightbulb Created with Sketch. 51
    To be fair, there is suplemental information released. That is what it looks like to me...

    Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii52, https://doi.org/10.1093/neuonc/noaa215.210
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.